OncoMethylome
Europe, Liege, Belgium, Liège
Description
OncoMethylome is a molecular diagnostics company developing gene methylation tests for early detection of cancer.
Investor Profile
OncoMethylome has made 2 investments, with 0 in the past 12 months and 50% as lead.
Stage Focus
- Series C (50%)
- Series B (50%)
Country Focus
- Germany (100%)
Industry Focus
- Biotechnology
- Health Care
- Oncology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
